Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Anika Therapeutics | ANIK | 6. nov 2024 | 17.27 | +5.95 |
Anixa Biosciences | ANIX | 6. nov 2024 | 3.45 | -3.36 |
Annaly Capital Management | NLY | 6. nov 2024 | 19.05 | -1.14 |
Annaly Capital Management F Pref | NLY-F | 6. nov 2024 | 25.88 | -0.04 |
Annaly Capital Management G Pref | NLY-G | 6. nov 2024 | 25.50 | -0.16 |
Annaly Capital Management I Pref | NLY-I | 6. nov 2024 | 25.87 | +0.08 |
Annexon | ANNX | 6. nov 2024 | 7.47 | +3.03 |
Annovis Bio | ANVS | 6. nov 2024 | 8.58 | +3.13 |
ANSYS | ANSS | 6. nov 2024 | 333.62 | +2.82 |
Antelope Enterprise | AEHL | 6. nov 2024 | 0.28 | -13.51 |
Anterix | ATEX | 6. nov 2024 | 34.97 | +2.91 |
Antero Midstream | AM | 6. nov 2024 | 15.18 | +3.90 |
Antero Resources | AR | 6. nov 2024 | 28.65 | +7.34 |
Anywhere Real Estate | HOUS | 6. nov 2024 | 4.00 | -0.99 |
Aon | AON | 6. nov 2024 | 381.28 | +3.41 |
APA | APA | 6. nov 2024 | 24.73 | +4.92 |
Apartment Investment and Management | AIV | 6. nov 2024 | 8.68 | +1.28 |
Apellis Pharmaceuticals | APLS | 6. nov 2024 | 28.83 | +2.69 |
APi Group | APG | 6. nov 2024 | 36.98 | +5.33 |
Apogee Enterprises | APOG | 6. nov 2024 | 84.12 | +5.72 |
Apogee Therapeutics | APGE | 6. nov 2024 | 58.81 | +0.89 |
Apollo Commercial Real Estate Finance | ARI | 6. nov 2024 | 9.11 | +2.47 |
Apollo Global Management | APO | 6. nov 2024 | 163.67 | +9.65 |
Apollomics A | APLM | 6. nov 2024 | 0.12 | +1.14 |
AppFolio A | APPF | 6. nov 2024 | 228.10 | +5.56 |
Appian A | APPN | 6. nov 2024 | 40.50 | +4.73 |
Apple | AAPL | 6. nov 2024 | 222.72 | -0.33 |
Apple Hospitality REIT | APLE | 6. nov 2024 | 15.74 | +6.64 |
Applied Digital | APLD | 6. nov 2024 | 7.07 | +10.99 |
Applied DNA Sciences | APDN | 6. nov 2024 | 0.18 | -3.27 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.